175 related articles for article (PubMed ID: 33240930)
1. Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types.
Yang C; Pan H; Shen L
Front Mol Biosci; 2020; 7():576269. PubMed ID: 33240930
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types.
Lv JW; Zheng ZQ; Wang ZX; Zhou GQ; Chen L; Mao YP; Lin AH; Reiter RJ; Ma J; Chen YP; Sun Y
J Pineal Res; 2019 Apr; 66(3):e12557. PubMed ID: 30638277
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers.
Kazakova E; Rakina M; Sudarskikh T; Iamshchikov P; Tarasova A; Tashireva L; Afanasiev S; Dobrodeev A; Zhuikova L; Cherdyntseva N; Kzhyshkowska J; Larionova I
Front Oncol; 2023; 13():1058337. PubMed ID: 36895491
[TBL] [Abstract][Full Text] [Related]
4. A pan-cancer analysis of the oncogenic role of secreted phosphoprotein 1 (SPP1) in human cancers.
Liu Y; Ye G; Dong B; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Qi Y
Ann Transl Med; 2022 Mar; 10(6):279. PubMed ID: 35433956
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment.
Zhao Y; Zhang M; Pu H; Guo S; Zhang S; Wang Y
Front Oncol; 2020; 10():585961. PubMed ID: 33552963
[TBL] [Abstract][Full Text] [Related]
6. Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers.
Zeng P; Zhang X; Xiang T; Ling Z; Lin C; Diao H
Bioengineered; 2022 Feb; 13(2):3221-3239. PubMed ID: 35067176
[TBL] [Abstract][Full Text] [Related]
7. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
9. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
[No Abstract] [Full Text] [Related]
10. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
11. Comprehensive Analysis to Identify
Zhao K; Ma Z; Zhang W
Front Genet; 2021; 12():732822. PubMed ID: 35058964
[No Abstract] [Full Text] [Related]
12. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
14. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
Front Genet; 2020; 11():547. PubMed ID: 32595698
[TBL] [Abstract][Full Text] [Related]
16. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
Iglesia MD; Parker JS; Hoadley KA; Serody JS; Perou CM; Vincent BG
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27335052
[TBL] [Abstract][Full Text] [Related]
17. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
18. LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients.
Zheng X; Liao X; Nie L; Lin T; Xu H; Yang L; Shen B; Qiu S; Ai J; Wei Q
Front Cell Dev Biol; 2021; 9():748280. PubMed ID: 35004669
[No Abstract] [Full Text] [Related]
19. Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity.
Chen F; Fan Y; Liu X; Zhang J; Shang Y; Zhang B; Liu B; Hou J; Cao P; Tan K
Front Mol Biosci; 2021; 8():789703. PubMed ID: 35087869
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies.
Das S; Camphausen K; Shankavaram U
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32882873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
